Waystar (NASDAQ:WAY) Sets New 12-Month Low – What’s Next?

Waystar Holding Corp. (NASDAQ:WAY)’s stock price reached a new 52-week low on Wednesday . The company traded as low as $19.37 and last traded at $19.39, with a volume of 1951875 shares. The stock had previously closed at $19.90.

Analysts Set New Price Targets

WAY has been the subject of a number of research analyst reports. Evercore set a $27.00 price objective on shares of Waystar in a research report on Wednesday, February 18th. UBS Group reduced their price objective on shares of Waystar from $41.00 to $37.00 and set a “buy” rating for the company in a research report on Thursday, April 30th. The Goldman Sachs Group reduced their price objective on shares of Waystar from $44.00 to $38.00 and set a “buy” rating for the company in a research report on Wednesday, February 18th. Morgan Stanley started coverage on shares of Waystar in a research report on Monday, March 30th. They set an “equal weight” rating and a $28.00 price objective for the company. Finally, TD Cowen restated a “buy” rating on shares of Waystar in a research report on Wednesday, February 18th. Three equities research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Waystar has a consensus rating of “Buy” and a consensus target price of $36.14.

Waystar Stock Performance

The firm has a market cap of $3.61 billion, a PE ratio of 28.10, a P/E/G ratio of 0.74 and a beta of 0.21. The firm has a 50-day moving average price of $23.69 and a two-hundred day moving average price of $28.66. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.37.

Waystar (NASDAQ:WAY) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.03. The firm had revenue of $313.87 million for the quarter, compared to analyst estimates of $311.74 million. Waystar had a net margin of 10.90% and a return on equity of 6.99%. Waystar’s quarterly revenue was up 22.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.32 earnings per share. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. Research analysts forecast that Waystar Holding Corp. will post 1.45 EPS for the current fiscal year.

Hedge Funds Weigh In On Waystar

Institutional investors and hedge funds have recently bought and sold shares of the business. Royal Bank of Canada grew its holdings in Waystar by 11.3% in the 1st quarter. Royal Bank of Canada now owns 21,609 shares of the company’s stock valued at $808,000 after buying an additional 2,195 shares in the last quarter. AQR Capital Management LLC purchased a new stake in Waystar in the 1st quarter valued at $203,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Waystar by 91.1% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,911 shares of the company’s stock valued at $1,753,000 after buying an additional 22,364 shares in the last quarter. NewEdge Advisors LLC purchased a new stake in Waystar in the 1st quarter valued at $234,000. Finally, Goldman Sachs Group Inc. grew its holdings in Waystar by 13.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 747,268 shares of the company’s stock valued at $27,918,000 after buying an additional 88,256 shares in the last quarter.

About Waystar

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.